Pfizer has gained accelerated approval from the US FDA for BRAFTOVI in conjunction with cetuximab and mFOLFOX6 for treating mCRC.

Ellipses Pharma Limited ( “ Ellipses”), a global drug development company focused on accelerating the development of ...

Over the last year, each of my patients has not asked me about creams they should use but whether they contained ceramides or ...